Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P240: Surgical resection in a tertiary IBD centre in Southeastern Brazil: clinical aspects and associated factors

ECCO '19 Copenhagen

Year: 2019
Authors:

S. da Costa Ferreira*1, L. Cavalcanti Dias Xavier1, P. Maria Lemos1, L. Rose Otoboni Aprile1, B. Bezerra Martins de Oliveira1, I. Steltenpool Tonin Borges1, R. Serafim Parra2, M. Ribeiro Feitosa2, O. Féres2, J. Joaquim Ribeiro da Rocha2, L. E. de Ameida Troncon1

1Division of Gastroenterology, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Brazil, Ribeirao Preto, Brazil, 2Division of Coloproctology, Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, Brazil, Ribeirao Preto, Brazil

P241: Focussing on the future: reducing barriers and improving access to IBD specialty care

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Heisler*1, O. Kits2, S. Veldhuyzen van Zanten3, J. Jones2

1Nova Scotia Health Authority, Halifax, Canada, 2Dalhousie University, Halifax, Canada, 3University of Alberta, Edmonton, Canada

P242: Accuracy of Doppler transabdominal ultrasound in assessing disease severity and extent in IBD

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Sagami*1, T. Kobayashi1, T. Kanazawa2, K. Aihara2, H. Morikubo1,3, R. Ozaki1,3, S. Okabayashi1, M. Matsubayashi1,3, A. Fuchigami1,3, H. Kiyohara1,3, M. Nakano1,3, T. Hibi1

1Kitasato University Kitasato Institute Hospital, Center for Advanced IBD Research and Treatment, Tokyo, Japan, 2Kitasato University Kitasato Institute Hospital, Department of Clinical Laboratory, Tokyo, Japan, 3Kitasato University Kitasato Institute Hospital, Department of Gastroenterology and Hepatology, Tokyo, Japan

P243: The different role of histology in ulcerative colitis and Crohn’s disease: a retrospective study in a single referral centre

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Pagnini*1, M. C. Di Paolo1, D. Campagna2, L. Costarelli2, F. Monardo2, F. R. Piro2, L. D'Alba1, M. A. De Cesare1, L. Pallotta1, R. Urgesi1, G. Villotti1, M. A. Vitale1, M. Giordano2, M. G. Graziani1

1S. Giovanni Addolorata Hospital, Gastroenterology and Digestive Endoscopy, Rome, Italy, 2S. Giovanni Addolorata Hospital, Anatomy and Pathological Histology, Rome, Italy

P244: Use of complementary and alternative medicine in patients with inflammatory bowel disease in Germany

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Klaus*1, M. Kretschmer1, J. Berthold1, L. Rauschek1, E. Rottler2, L. Schulte1, R. Eisele3, C. von Tirpitz4, M. Sularz1

1Ulm University Hospital, Department of Internal Medicine I, Ulm, Germany, 2Ulm University Hospital, Department of Psychosomatic Medicine and Psychotherapy, Ulm, Germany, 3Krankenhaus Blaubeuren, Innere Medizin, Blaubeuren, Germany, 4Krankenhaus Biberbach, Innere Medizin, Biberach, Germany

P245: Pulmonary function tests in asymptomatic patients with inflammatory bowel disease: preliminary results of a single-centre cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Fragaki*1, E. Pasparaki2, E. Bibaki2, G. Kounalakis2, E. Ferdoutsis2, G. Paspatis1, G. Meletis2, K. Karmiris1

1Venizeleio General Hospital, Gastroenterology, Heraklion, Greece, 2Venizeleio General Hospital, Thoracic Medicine, Heraklion, Greece

P246: Clinical outcomes of 2012 ECCO/ESPGHAN guidelines in a large cohort of children with ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Aloi*1, M. Distante1, A. Jaljaa1, S. Oliva1, S. Isoldi1, F. Valitutti1, S. Mallardo1, S. Cucchiara1

1Sapienza University of Rome, Department of Pediatrics, Pediatric Gastroenterology Unit, Rome, Italy

P247: Understanding patient perspectives on dysplasia cancer risk and its management

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Kabir*1,2, S. Thomas-Gibson1,2, A. Hart1,2, O. Faiz1,2, J. Warusavitarne1,2, A. Wilson1,2

1St Mark's Hospital, London, UK, 2Imperial College, London, UK

P248: Correlation of faecal calprotectin levels and sonographic measurements in patients with inflammatory bowel diseases

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Les*1, R. Costache1, L. Gheorghe1, C. Gheorghe1

1Fundeni Clinical Institute, Gastroenterology, Bucharest, Romania

P249: Validation of a Novel Integral Disease Index (NIDI) for evaluating the grade of activity in Mexican patients with ulcerative colitis: a prospective cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Yamamoto-Furusho*1, K. Bozada-Gutiérrez1, F. Bojalil-Romano1, R. Barreto-Zuñiga2, B. Martínez-Benitez3

1IBD Clinic, Department of Gastroenterology, Instituto Nacional de Ciencias Medicas y Nutricion, Gastroenterology, Mexico, Mexico, 2Instituto Nacional de Ciencias Medicas y Nutricion, Endoscopy, Mexico, Mexico, 3Instituto Nacional de Ciencias Medicas y Nutricion, Pathology, Mexico, Mexico

P250: Use of complementary and alternative medicine is associated with chronic fatigue and lower health-related quality of life in patients with inflammatory bowel disease 20 years after diagnosis: results from the IBSEN study

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Opheim*1,2, J. Jahnsen2,3, G. Huppertz-Hauss4, T. Bernklev2,5, O. Høie6, M. Bjørn1,2

1Oslo University Hospital, Department of Gastroenterology, Oslo, Norway, 2University of Oslo, Faculty of Medicine, Oslo, Norway, 3Akershus University Hospital, Department of Gastroenterology, Oslo, Norway, 4Telemark Hospital Trust, Department of Gastroenterology, Skien, Norway, 5Vestfold Hospital Trust, Department of Research and Innovation, Tønsberg, Norway, 6Sørlandet Hospital Trust, Department of Gastroenterology, Arendal, Norway

P251: RAID Dx: the first test based on faecal microbiota to differentiate irritable bowel syndrome from inflammatory bowel diseases

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Amoedo*1,2, S. Ramió-Pujol1, A. Bahí3, C. Puig-Amiel3, L. Oliver1, L. Torrealba4, G. Ibáñez-Sanz5, A. Clos6, M. Mañosa6, F. Cañete6, I. Marín6, P. Torres6, P. Gilabert5, J. O. Miquel-Cusachs4, D. Busquets4, M. Serra-Pagès1, M. Sàbat7, J. Serra6, E. Domènech6, J. Guardiola5, F. Mearin8, L. J. Garcia-Gil1,2, X. Aldeguer1,3,4

1GoodGut SL, Girona, Spain, 2Universitat de Girona, Microbiology, Girona, Spain, 3Institut de Investigació Biomèdica de Girona, Girona, Spain, 4Hospital Universitari Dr. Josep Trueta, Girona, Spain, 5Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain, 6Hospital Universitari Germans Trias I Pujol, CIBEREHD, Badalona, Spain, 7Hospital de Santa Caterina, Salt, Spain, 8Centro Médico Teknon, Barcelona, Spain

P252: Measuring the mediating effects of Mayo score components for tofacitinib on disease-specific quality of life in ulcerative colitis: data from the OCTAVE programme

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Dubinsky1, A. Bushmakin2, M. DiBonaventura3, J. Cappelleri4, L. Salese5, E. Maller5, A. Armuzzi*6

1Mount Sinai, New York, USA, 2Pfizer Inc., New York, USA, 3Pfizer Inc., Patient and Health Impact, New York, USA, 4Pfizer Inc., Groton, USA, 5Pfizer Inc., Collegeville, USA, 6Fondazione Policlinico Gemelli IRCCS - Università Cattolica del Sacro Cuore, Rome, Italy

P253: The impact of storage time and freeze–thaw cycles on faecal calprotectin concentration in inflammatory bowel disease patients and controls

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Caenepeel*1, K. Machiels1, S. Vieira-Silva2, N. Ardeshir Davani1, M. Ferrante1,3, S. Vermeire1,3

1KU Leuven, TARGID, Leuven, Belgium, 2Rega Institute for Medical Research, Microbiology and Immunology, Leuven, Belgium, 3University hospitals Leuven, Gastroenterology and Hepatology, Leuven, Belgium

P254: Re-defining the concept of endoscopic and histological healing by using electronic virtual chromoendoscopy and probe confocal endomicroscopy in ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Iacucci*1,2,3,4, R. Cannatelli3, S. X. Gui5, B. C. Lethebe6, A. Bazarova3, G. Gkoutos3, G. Kaplan7, R. Panaccione7, R. Kiesslich8, S. Ghosh1,3,4

1University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, UK, 2University of Calgary, IBD Unit, Calgary, Canada, 3University of Birmingham, Institute of Translational Medicine, Birmingham, UK, 4National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, UK, 5University of Calgary, Department of Pathology, Calgary, Canada, 6University of Calgary, Research Unit, Calgary, Canada, 7University of Calgary, IBD Unit, Birmingham, UK, 8HSK Hospital, Division of Gastroenterology, Wiesbaden, Germany

P255: Perceived disease severity and treatment satisfaction among patients with ulcerative colitis in Europe

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Armuzzi*1, M. Tarallo2, D. Bargo3, J. Lucas4, D. Bluff4, B. Hoskin4, L. Salese5, J. Cappelleri6, C. Kayhan5, M. DiBonaventura8

1Fondazione Policlinico Gemelli IRCCS – Università Cattolica del Sacro Cuore, Rome, Italy, 2Pfizer Inc., Rome, Italy, 3Pfizer Inc., New York, USA, 4Adelphi Real World, Macclesfield, UK, 5Pfizer Inc., Collegeville, USA, 6Pfizer Inc., Groton, USA, 8Pfizer Inc., Patient and Health Impact, New York, USA

P256: Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Laterza*1, M. E. Ainora1, M. Garcovich1, A. Poscia2, A. Lupascu3, L. Riccardi1, F. Scaldaferri1, A. Armuzzi4, A. Gasbarrini1, G. L. Rapaccini4, M. Pompili1, M. A. Zocco1

1Fondazione Policlinico A. Gemelli IRCCS, Internal Medicine and Gastroenterology, Rome, Italy, 2Catholic University, Institute of Public Health, Rome, Italy, 3Fondazione Policlinico A. Gemelli IRCCS, Angiology, Rome, Italy, 4Fondazione Policlinico A. Gemelli IRCCS, Presidio Columbus, Rome, Italy

P257: Monitoring of calprotectin levels in IBD patients with point-of-care test CalproSmart™

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Ulanova*1, E. Moerk1

1Calpro AS, Lysaker, Norway

P258: Abdominal pain and its relationship with clinical outcomes, biomarker levels, and health-related quality of life in patients with moderate to severe ulcerative colitis: data from U-ACHIEVE, a Phase 2b study of upadacitinib

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Danese*1, E. Louis2, E. V. Loftus Jr3, F. Cataldi4, H. Guay4, W-J. Lee4, S. Ghosh5

1Istituto Clinico Humanitas, Department of Gastroenterology, Milan, Italy, 2University Hospital CHU of Liège, Liège, Belgium, 3Mayo Clinic College of Medicine, Rochester, USA, 4AbbVie Inc., North Chicago, USA, 5University of Birmingham, Institute of Immunology and Immunotherapy, NIHR Biomedical Research Centre, Institute of Translational Medicine, Birmingham, UK

P259: Systematic assessment of patient self-reported signs, symptoms, and nutrition behaviour

ECCO '19 Copenhagen

Year: 2019
Authors:

V. Pittet*1, M. H. Maillard2, P. Michetti2, Swiss IBD Cohort Study1

1Institute of Social and Preventive Medicine, Healthcare Evaluation Unit, Lausanne, Switzerland, 2Crohn and Colitis Center, Gastroenterology Beaulieu SA, Lausanne, Switzerland